Between Nov @ , @ , and April @ , @ , @ premenopausal women with hormone-receptor positive breast cancer were enrolled in TEXT or SOFT to receive unmasked adjuvant treatment with @ years of exemestane plus OFS or tamoxifen plus OFS .